BioXcel Therapeutics

BTAI

NASDAQHealth Care

Income Statement

Total Revenue$2.27M

Gross Profit$122K

Operating Income$-67.25M

EBITDA$-44.16M

EBIT$-44.47M

Pre-tax Income$-69.9M

Net Income$-59.6M

Cash Equivalent$50.16M

Total Debt$103.1M

Book Value$-81.35M

Book Value Per Share-34.34

Return on Equity (ROE)-215.83%

Return on Assets (ROA)-155.46%

Return on Invested Capital (ROI)-97.56%

Net Profit Margin-2630.14%

Current Ratio1.68

Quick Ratio1.41

Long-Term Debt / Equity1.21